Technology
Health
Biotechnology

ENDRA Life Sciences

$3.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-3.43%) Today
+$0.06 (1.94%) After Hours

Why Robinhood?

You can buy or sell NDRA and other stocks, options, ETFs, and crypto commission-free!

About

ENDRA Life Sciences, Inc. engages in the development of ultrasound technology for the pre-clinical research market. It develops Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. Read More The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Employees
11
Headquarters
Ann Arbor, Michigan
Founded
2007
Market Cap
23.83M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
237.68K
High Today
$3.31
Low Today
$3.05
Open Price
$3.27
Volume
110.80K
52 Week High
$5.75
52 Week Low
$1.44

Collections

Technology
Health
Biotechnology
Medical
2017 IPO
US
North America

News

Seeking AlphaMar 11

ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q4 2018 Results - Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2018 Earnings Conference Call March 11, 2019 4:30 PM ET Company Participants Chris Tyson - Managing Director, MZ North America Francois Michelon - CEO David Wells - CFO Michael Thornton - Chief Technology Officer Conference Call Participants Kyle Bauser - Dougherty and Company Brooks O'Neil - Lake Street Capital Markets Paul Bienstock - National Securities Michael Brcic - National Securities Bill Morrison - National Securities Bruce Jackson - The Benchma...

705
MarketBeatMar 8

Stock Price, News, & Analysis for ENDRA Life Sciences

ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based the...

56

Earnings

-$0.72
-$0.56
-$0.39
-$0.23
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
-$0.28 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.